Full Press Release Details
Immutep’s Phase II TACTI-002 Study Reports Encouraging Data at SITC.
IMMP
Immutep’s Phase II TACTI-002 Study Reports Encouraging Data at SITC
Key Takeaway: Immutep’s Phase II TACTI-002 Study Reports Encouraging Data at SITC